Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.
J. Clin. Endocrinol. Metab., Apr;95(4):1916-23 (2010)
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.
Mol. Ther., Nov;16(11):1805-12 (2008)
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
J. Clin. Endocrinol. Metab., Sep;89(9):4312-9 (2004)
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
J. Clin. Endocrinol. Metab., Sep;89(9):4649-55 (2004)
Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic.
Curr. Diab. Rep., Jun;4(3):213-8 (2004)
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
Diabetes., Jun;52(6):1364-70 (2003)
Effect of point-of-care on maintenance of glycemic control as measured by A1C.
Diabetes Care., Mar;30(3):713-5 (2007)
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Am. J. Physiol. Endocrinol. Metab., Jun;292(6):E1775-81 (2007)
Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus.
Expert Opin Pharmacother., Jun;7(8):1055-64 (2006)
Metabolic and molecular basis of insulin resistance.
J Nucl Cardiol., 10(3):311-23 (2003)
Paradoxical Changes in Muscle Gene Expression in Insulin Resistance following Acipimox Treatment
Effect of PPAR-alpha and PPAR-gamma Agonists on Glucose and Lipid Metabolism in Type 2 Diabetes
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes
American Journal of Physiology- Endocrinology and Metabolism
Effect of point-of-care on maintenance of glycemic control as measured by A1C
Exenatide: A GLP-1 Receptor Agonist as Novel Therapy for type 2 Diabetes Mellitus
Expert Opinions in Pharmacotherapy
A big fat wedding: association of adiponectin with coronary vascular lesions
JACC: Journal of the American College of Cardiology
Predictors of Improved Glycemic Control with Thiazolidinedione Therapy in Type 2 Diabetic Patients: A Practical Approach for the Primary Care Physician
The British Journal of Diabetes & Vascular Disease
Lipid Infusion Induces an Inflammatory/Fibrotic Response and Decreases Expression of Nuclear Encoded Mitochondrial Genes in Human Skeletal Muscle
The Journal of Biological Chemistry
Resistance is Associated with Impaired Nitric Oxide Synthase Activity in Skeletal Muscle of Type 2 Diabetic Subjects
Journal of Clinical Endocrinology & Metabolism
Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long Chain-Fatty Acyl-CoAs and Insulin Action in Patients with Type 2 Diabetes